Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 2 Interventional Results available

A Study of MK-3655 in Individuals With Pre-cirrhotic Nonalcoholic Steatohepatitis (NASH) (MK-3655-001)

ClinicalTrials.gov ID: NCT04583423

Public ClinicalTrials.gov record NCT04583423. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 12:18 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2b Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of MK-3655 in Individuals With Pre-cirrhotic Nonalcoholic Steatohepatitis.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study will evaluate the effect of each dose of MK-3655 versus placebo on the percentage of individuals with NASH resolution without worsening of fibrosis after 52 weeks. The primary hypothesis of the study is that at least 1 dose of MK-3655 is superior to placebo with respect to the percentage of individuals with NASH resolution without worsening of fibrosis after 52 weeks.

Study identification

NCT ID
NCT04583423
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2
Lead sponsor
Merck Sharp & Dohme LLC
Industry
Enrollment
183 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 80 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 11, 2020 (Actual)
Primary completion
Apr 13, 2023 (Actual)
Completion
Apr 13, 2023 (Actual)
Last update posted
Jul 17, 2025

2020 – 2023

United States locations

U.S. sites
48
U.S. states
16
U.S. cities
40
Facility City State ZIP Site status
Adobe Clinical Research, LLC ( Site 2644) Tucson Arizona 85712 —
Arizona Liver Health ( Site 9026) Tucson Arizona 85712 —
Del Sol Research Management ( Site 2674) Tucson Arizona 85715 —
Arkansas Gastroenterology - North Little Rock ( Site 9015) North Little Rock Arkansas 72117 —
Hope Clinical Research, Inc. ( Site 2601) Canoga Park California 91303 —
Velocity Clinical Research, Huntington Park ( Site 9022) Huntington Park California 90255 —
UCSD - Altman Clinical and Translational Research Institute -UC San Diego NAFLD Research Center ( Si La Jolla California 92037 —
Ruane Clinical Research Group, Inc ( Site 9014) Los Angeles California 90036 —
Velocity Clinical Research, Westlake ( Site 9013) Los Angeles California 90057 —
Catalina Research Institute, LLC ( Site 2643) Montclair California 91763 —
Velocity Clinical Research, Panorama City ( Site 9001) Panorama City California 91402 —
California Liver Research Institute ( Site 9025) Pasadena California 91105 —
Quest Clinical Research ( Site 9011) San Francisco California 94115 —
Velocity Clinical Research, Santa Ana ( Site 9002) Santa Ana California 92704 —
Peak Gastroenterology Associates ( Site 2645) Colorado Springs Colorado 80920 —
Top Medical Research, Inc ( Site 2673) Cutler Bay Florida 33189 —
Covenant Metabolic Specialists, LLC ( Site 9027) Fort Myers Florida 33912 —
North Florida South Georgia Veterans Health System ( Site 2613) Gainesville Florida 32608 —
Indago Research and Health Center Inc ( Site 2610) Hialeah Florida 33012 —
Sweet Hope Research Specialty Inc ( Site 2660) Hialeah Florida 33016 —
Genoma Research Group, Inc. ( Site 2669) Miami Florida 33173 —
Floridian Clinical Research, LLC ( Site 2656) Miami Lakes Florida 33016-1518 —
Ocean Blue Medical Research Center Inc ( Site 2667) Miami Springs Florida 33166 —
Sensible Healthcare Llc ( Site 2607) Ocoee Florida 34761 —
Synexus Research ( Site 2672) Orlando Florida 32806 —
Southeast Clinical Research Center ( Site 9003) Dalton Georgia 30720 —
The University of Iowa ( Site 2655) Iowa City Iowa 52242 —
Legacy Clinical Solutions: Tandem Clinical Research, LLC ( Site 2650) Marrero Louisiana 70072 —
The National Diabetes & Obesity Research Institute ( Site 9017) Biloxi Mississippi 39532 —
Kansas City Research Institute ( Site 9018) Kansas City Missouri 64131 —
Excel Clinical Research, LLC ( Site 2603) Las Vegas Nevada 89109 —
Velocity Clinical Research, Syracuse ( Site 9016) East Syracuse New York 13057 —
NYU Langone Health, New York ( Site 2627) New York New York 10016 —
Hillmont G.I. ( Site 9019) Flourtown Pennsylvania 19031 —
Regional Gastroenterology Associates of Lancaster, LTD ( Site 9020) Lancaster Pennsylvania 17601 —
Regional Gastroenterology Associates of Lancaster, LTD ( Site 9004) Wyomissing Pennsylvania 19610 —
Premier Medical Group ( Site 9010) Clarksville Tennessee 37040 —
Texas Clinical Research Institute ( Site 2619) Arlington Texas 76012 —
The Liver Institute at Methodist Dallas Medical Center ( Site 2638) Dallas Texas 75203 —
DHR Health Institute for Research and Development ( Site 9006) Edinburg Texas 78539 —
South Texas Research Institute ( Site 9012) Edinburg Texas 78539 —
Baylor College of Medicine - Advanced Liver Therapies ( Site 2670) Houston Texas 77030 —
The Crofoot Research Center, Inc. ( Site 2611) Houston Texas 77098 —
Quality Research ( Site 9024) San Antonio Texas 78209 —
American Research Corporation at Texas Liver Institute ( Site 2634) San Antonio Texas 78215 —
Clinical Trials of Texas, LLC ( Site 2614) San Antonio Texas 78229 —
Impact Research Institute ( Site 2685) Waco Texas 76710 —
Virginia Commonwealth University Health System ( Site 2657) Richmond Virginia 23298 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 132 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04583423, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 17, 2025 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT04583423 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →